| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/02/2012 | US20120027680 Oxime conjugates and methods for their formation and use |
| 02/02/2012 | US20120027677 Prion-specific peptoid reagents |
| 02/02/2012 | US20120027676 Modified sodium iodide symporter proteins and uses thereof |
| 02/02/2012 | US20120027675 Targeting pulmonary epithelium using adrp |
| 02/02/2012 | US20120027674 Il-18 receptor as a novel target of regulatory t cells in cancer |
| 02/02/2012 | US20120024743 Transdermal pharmaceutical preparations |
| 02/02/2012 | DE102010033575A1 ASPP2-Splicevariante ASPP2 splice variant |
| 02/02/2012 | DE102010032482A1 New receptor agonist having renin-suppressing activity, antihypertrophic activity and influence of second messenger cyclic guanosine monophosphate during vasodilation, natriuresis and diuresis, useful to treat e.g. nephrotic syndrome |
| 02/02/2012 | CA2807023A1 Collagen powder and/or collagen-derived powder, and production method for the same |
| 02/02/2012 | CA2806973A1 Preservative free bimatoprost solutions |
| 02/02/2012 | CA2806749A1 Glp-1 receptor agonist compounds having stabilized regions |
| 02/02/2012 | CA2806606A1 Pharmaceutical compositions for the treatment of left ventricular diastolic dysfunction comprising an apolipoprotein peptide/phospholipid complex |
| 02/02/2012 | CA2806399A1 Recombinantly expressed insulin polypeptides and uses thereof |
| 02/02/2012 | CA2805864A1 Stabilization of fsh |
| 02/02/2012 | CA2805825A1 Anti-viral agent |
| 02/02/2012 | CA2805760A1 Inhibition of cyp3a drug metabolism |
| 02/01/2012 | EP2412758A1 Polyion complex comprising hydrophobized polyamino acid and use of same |
| 02/01/2012 | EP2412730A1 Interferon-alpha (ifn-alpha ) fused protein having ifn-alpha and cytoplasmic transduction peptide (ctp) |
| 02/01/2012 | EP2412727A2 Metallothionein-derived peptide fragments |
| 02/01/2012 | EP2412726A2 Metallothionein-derived peptide fragments |
| 02/01/2012 | EP2412719A1 Chi-conotoxin peptides |
| 02/01/2012 | EP2412385A1 Liquid formulation of FSH |
| 02/01/2012 | EP2412381A1 Use of G-CSF for treating strokes |
| 02/01/2012 | EP2412380A1 Epitopes related to coeliac disease |
| 02/01/2012 | EP2412379A1 Composition for regulating autonomic nervous activity and method for regulating autonomic nerve |
| 02/01/2012 | EP2411521A1 Compositions for stimulation of mammalian innate immune resistance to pathogens |
| 02/01/2012 | EP2411406A2 Isoform nell-1 peptide |
| 02/01/2012 | EP2411042A1 Tissue kallikrein for the treatment of pancreatic -cell dysfunction |
| 02/01/2012 | EP2411041A1 Fertilization modulation compounds and process for implementing them |
| 02/01/2012 | EP2411040A1 Site-directed pegylation of arginases and the use thereof as anti-cancer and anti-viral agents |
| 02/01/2012 | EP2411039A2 Glycoconjugate vaccines |
| 02/01/2012 | EP2411038A2 Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use |
| 02/01/2012 | EP2411037A1 Fast-acting insulin formulation |
| 02/01/2012 | EP2411036A1 Methods for improving neurological outcome after neural injury and neurodegenerative disease |
| 02/01/2012 | EP2411035A1 Oncofetal antigen/immature laminin receptor peptides for the sensitization of dendritic cells for cancer therapy |
| 02/01/2012 | EP2411034A1 Promotion of neuronal integration in neural stem cell grafts |
| 02/01/2012 | EP2411024A1 Factor viii variants and methods of use |
| 02/01/2012 | EP2411007A2 Modulating ires-mediated translation |
| 02/01/2012 | EP2411000A1 Pyrrolidine compounds which inhibit beta-secretase activity and methods of use thereof |
| 02/01/2012 | EP2218459B1 Sustained release composition containing sdf-1 |
| 02/01/2012 | EP2164532B1 Use of a haemoglobin for the preparation of dressings and resulting dressings |
| 02/01/2012 | EP2088152B1 N'-{n-[3-oxo-lupen-28-oyl]-9-aminononanoyl}-3-amino-3-phenylpropeonic acid and the pharmaceutically acceptable derivatives thereof, a method for the production and the use thereof in the form of a medicinal agent |
| 02/01/2012 | EP2077855B1 Therapeutic use of gba2 |
| 02/01/2012 | EP2061494B1 Regulation of expression of p140cap protein in tumors |
| 02/01/2012 | EP1978994B1 Bmp-7 variant compositions, methods and uses |
| 02/01/2012 | EP1942924B1 Use of vaccines for the treatment/prevention of the transmission of influenza pathogens between species |
| 02/01/2012 | EP1909811B1 Hox peptides as pbx modulators for the treatment of cancer |
| 02/01/2012 | EP1750750B1 Method of stabilizing proteins |
| 02/01/2012 | EP1699925B1 DCRS5 and p19 antagonists for therapy of asthma, allergy and COPD |
| 02/01/2012 | EP1663262B1 Bowman-birk inhibitor compositions for treatment of muscular atrophy and degenerative muscle disease |
| 02/01/2012 | EP1472353B1 Group b streptococcus antigen |
| 02/01/2012 | EP1425390B1 Materials and methods to promote repair of nerve tissue |
| 02/01/2012 | EP1334117B1 Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane-associating elements |
| 02/01/2012 | EP1286989B1 Prodrug of an ICE inhibitor |
| 02/01/2012 | CN1964989B 长效胰岛素衍生物及其方法 Long-acting insulin derivatives and methods |
| 02/01/2012 | CN1913917B 凝血酶肽衍生物的药物组合物 The pharmaceutical composition of the thrombin peptide derivative |
| 02/01/2012 | CN1867581B Il-21衍生物 Il-21 derivatives |
| 02/01/2012 | CN102341409A Crystalline insulin-conjugates |
| 02/01/2012 | CN102341119A Insulin formulations for rapid uptake |
| 02/01/2012 | CN102341118A Compositions and methods for visualizing and eliminating cancer stem cells |
| 02/01/2012 | CN102341117A Compositions and Methods |
| 02/01/2012 | CN102341116A Compositions for enhancing nail growth |
| 02/01/2012 | CN102341115A Peptide for prophylactic or therapeutic treatment of skin tumours in initial stages |
| 02/01/2012 | CN102341112A Method and means for producing tissues and tissues obtained |
| 02/01/2012 | CN102341110A Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy |
| 02/01/2012 | CN102337332A Gene and application of protein encoded by gene to preparation of medicine for diagnosing and treating breast cancer |
| 02/01/2012 | CN102337282A Thrombolysis protease gene NKS1 and purpose thereof |
| 02/01/2012 | CN102337273A Portunus trituberculatus anti-lipopolysaccharide factor PtALF-5 gene and encoding proteins and application thereof |
| 02/01/2012 | CN102337272A Portunus trituberculatus anti-lipopolysaccharide factor PtALF-3 gene and encoding proteins and application thereof |
| 02/01/2012 | CN102337271A Portunus trituberculatus anti-lipopolysaccharide factor PtALF-2 gene and encoding proteins and application thereof |
| 02/01/2012 | CN102337270A Coded pig beta defensin gene and method of preparing pig beta defensin by using same |
| 02/01/2012 | CN102337268A Human CTRP4 gene, its coding protein and their application |
| 02/01/2012 | CN102336833A CHD1L-TCTP binding blocking agent as well as medical combination with same and application thereof |
| 02/01/2012 | CN102336825A Balsam pear protein as well as preparation method and application of balsam pear protein in preparing antitumor medicament |
| 02/01/2012 | CN102336818A Peptide substance crystal B and its preparation method and use |
| 02/01/2012 | CN102336816A Schistosoma japonicum thioredoxin glutathione reductase (SjTGR) functional inhibitory peptides and application thereof |
| 02/01/2012 | CN102336815A Treatment of viral infections |
| 02/01/2012 | CN102336812A Polypeptide possessing angiogenesis inhibitory activity |
| 02/01/2012 | CN102336811A Novel small peptide capable of inhibiting new vessels and application thereof |
| 02/01/2012 | CN102336810A Angiotensin converting enzyme inhibitory peptide milky white peptide C1 and application thereof |
| 02/01/2012 | CN102336806A Angiotensin converting enzyme (ACE) inhibitor |
| 02/01/2012 | CN102336802A Glycyrrhetinic acid-modified lipid, liver targeting liposome, micelle and compound, and their preparation method |
| 02/01/2012 | CN102335457A Composition for tooth regeneration |
| 02/01/2012 | CN102335431A Administration composition as well as preparation and use methods thereof |
| 02/01/2012 | CN102335420A Composition containing haematococcus extract and collagen peptide and preparation method for composition |
| 02/01/2012 | CN102335419A Health-care product for relieving fatigue |
| 02/01/2012 | CN102335418A Health-care wine for relieving rheumatoid swelling |
| 02/01/2012 | CN102335417A Health-care product for restoring physical strength in later period of cold |
| 02/01/2012 | CN102335416A Compound Chinese medicinal composition for treating hog cholera and preparation method thereof |
| 02/01/2012 | CN102335415A Anti-inflammatory effect, implementation method and purpose of novel membrane molecule |
| 02/01/2012 | CN102335414A Rice prolamin bile acid adsorbent and preparation method thereof |
| 02/01/2012 | CN102335413A Preparation method, product and application of lactobacillus whole peptidoglycan with effect for resisting beta-lactoglobulin hypersusceptibility |
| 02/01/2012 | CN102335412A Health-care product for otitis media |
| 02/01/2012 | CN102335411A Novel process for preparing reduced glutathione monosodium salt preparation for injection |
| 02/01/2012 | CN101948528B 一种来自斑蝥的纤溶活性蛋白及其制备方法和应用 Fibrinolytic activity of the protein and its preparation method and application of cantharidin from |
| 02/01/2012 | CN101843893B 环孢素a在制备抗轮状病毒药物中的应用 Cyclosporine in the preparation of a medicament against rotavirus |
| 02/01/2012 | CN101829041B 一种杀菌止痒的妇科洗液 A fungicidal anti-itch lotion gynecological |
| 02/01/2012 | CN101822692B 一种水母毒素去溶血毒性的方法 A type of jellyfish toxin toxic to hemolysis method |
| 02/01/2012 | CN101805395B 具有抑制病毒混合感染活性的多肽 Inhibit the activity of mixed infection polypeptide |
| 02/01/2012 | CN101724026B 一种黑皮素类似物及其制备方法和应用 One kind of melanocortin analogue and its preparation method and application |